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ABSTRACT: 1 
Twelve riding horses were utilized to examine the effects of curcumin on intestinal parasites, 2 
inflammation, and the fecal shedding of Streptococcus bovis/equinus complex (SBEC), 3 
Clostridium difficile and Clostridium perfringens. Known for having anti-inflammatory, 4 
antimicrobial, and antiparasitic properties it was hypothesized that curcumin would decrease 5 
parasite shedding, inflammation, and opportunistic bacteria found in the GIT of riding horses. 6 
Horses were randomly assigned to one of the following treatments (n = 6/treatment): 1) no 7 
curcumin, control (CON); or 2) 15 g of 95% pure curcumin, (CUR). Curcumin was dosed per 8 
day for 30 d. Fecal samples were evaluated for shedding of ova and concentrations of selected 9 
bacteria. Blood samples taken pre and post riding intervals and evaluated for erythrocyte 10 
sedimentation rate (ESR) for inflammation. All data were analyzed for repeated measures. 11 
Treatment had no effect (P ≥ 0.58) on total fecal egg count, strongyles, or ascarids. Treatment 12 
had no effect on ESR (P ≤ 0.42); however, ESR decreased (P = 0.0006) on d 14 in CUR horses. 13 
Treatment had no effect (P ≥ 0.34) on concentrations of SBEC, C. difficile, or C. perfringens. 14 
Curcumin was not an effective compound against intestinal parasites or fecal microbial strains 15 
examined when administered for 30 days; but could potentially decrease inflammation.  16 
Curcumin has been observed to have many beneficial effects in other species, however, more 17 
research is needed to evaluate those benefits in horses. 18 
Keywords: Curcumin; Equine; Inflammation; Opportunistic bacteria; Parasites 19 
1. INTRODUCTION 20 
Horse intestinal parasites pose an economic and health risk that are of concern to both 21 
breeders and horse owners [1].  The body of a horse is host to millions of microscopic organisms 22 
who utilize the horse’s oxygen, nutrients, and body heat for survival. Parasites, such as 23 
Strongylidae (strongyles) can cause emaciation and anemia; while ascarids are known to cause a 24 
blockage in the intestines, which if not taken care of properly can lead to death [2,3]. Moreover, 25 
parasites, which can be found in the intestines of horses of all breeds, both sexes, and all age 26 
classes [4] can cause inflammation within the gastrointestinal tract (GIT). 27 
In addition to parasite-induced inflammation, inflammation can also occur due to the 28 
athletic lifestyle required of domesticated horses. Repetitive stress applied to the joints from 29 
speed work, jumping, and extreme hindquarter thrust, results in inflammatory changes to the 30 
bone structure, joint anatomy, and synovial fluid as well as predisposed factors. Although some 31 
horses are diagnosed with lameness in their younger years, many develop the progressive 32 
problem over time, whether it is mild or severe [5]. Therefore, inflammation in a horse can be 33 
due to several factors including, illness, injury, GIT parasites, and even an altered hindgut 34 
microbiome.  35 
The gut microbiota is one of the densest, most dynamic, and complex microorganism 36 
populations located in the body [6]. Gut microbiota act against pathogens, aid in digestion and 37 
absorption, and stimulate the immune system [7,8]. If the microbiome is altered, this could result 38 
in gastrointestinal diseases, such as enterocolitis, diarrhea, ulcers, anorexia, colic, and even death 39 
[9,10]. Streptococcus bovis/equinus complex (SBEC), Clostridium difficile, and Clostridium 40 
perfringens are bacteria found in the hindgut microbiome that are considered opportunistic due 41 
to GIT issues when the immune system is compromised. SBEC is a group of human and animal 42 
derived streptococci that are commensal, opportunistic pathogens, or food fermentation 43 
associates [11]. C. difficile is commonly associated with the onset of colic in horses, but has also 44 
been isolated from foals with diarrhea. C. perfringens causes enterocolitis in neonatal foals; in 45 
addition, this species produces endotoxins that can cause diarrhea and severe damage to the 46 
mucosa [9].When compared to other mammals, little research has been conducted on the 47 
microbiota in the GIT of horses [9]. 48 
Curcumin is the active ingredient in turmeric [Curcuma longa] that is not only known for 49 
having anti-inflammatory properties, but also possessing antimicrobial, wound healing, and 50 
antiparasitic properties [12,13]. In addition to curcumin having many biological activities, it is 51 
relatively safe and well-tolerated [14]. Testing curcumin has shown effective antiparasitic 52 
properties, it was an effective compound against R. cesticillus in birds [12], strongyles in cattle 53 
[15], and fecal egg shedding in goats [16]. The indication of the safety and efficacy of curcumin 54 
provided a solid basis for evaluating its antiparasitic and antimicrobial properties in riding 55 
horses. We hypothesized that curcumin would decrease parasite shedding, inflammation, and 56 
opportunistic bacteria found in the GIT of riding horses. The main objectives were to evaluate 57 
fecal shedding of intestinal parasite ova and selected opportunistic bacteria as well as erythrocyte 58 
sedimentation rate when dosing curcumin at 15 g per day for 30 days to riding horses. 59 
2. Materials and Methods 60 
Twelve horses, ten Southern Illinois University of Carbondale (SIUC) owned riding 61 
horses and two privately owned riding horses were used for this study. All horses were between 62 
the ages of five and twenty years old, and did not have any concurrent illnesses and/or ailments; 63 
they also did not receive any medications or dewormer for 30 days prior to the commencement 64 
of this research trial. The predominate breed utilized was Quarter Horse (nine), one mustang, one 65 
warmblood, and one draft horse.  Care and handling of animals used in this study was approved 66 
by Southern Illinois University Animal Care and Use Committee (Protocol 15-041). 67 
Horses were randomly assigned to one of the following treatments: 1) no curcumin 68 
(CON) or 2) 15 g of 95% pure curcumin (CUR). The average age of the CON horses was 12.5 69 
years old ± 7 years, while the average age of the CUR horses was 13.5 ± 7 years.  There were 3 70 
gelding and 3 mares on CON and 6 mares on CUR treatments.  The CON horses received 3 - 4 71 
alfalfa cubes, moistened with water, and mashed. The CUR horses received the same alfalfa cube 72 
mash as CON horses but with 15 g of curcumin (Noble Elephant Supplement, San Dimas, CA) 73 
mixed into the mash. The dosage of curcumin was based off the recommended dose of one 74 
tablespoon, which equates to 15 g per horse [17]. Horses were gathered and samples were 75 
collected at 1100 daily. Once samples were collected horses were fed either CON or CUR 76 
treatment. All horses were housed on pasture and grazed ad libitum when not ridden. All horses 77 
were ridden for an average of three hours daily for four days a week. 78 
2.1 Analysis of Intestinal Parasites 79 
A fresh fecal sample was collected from each horse at 1100, prior to initiation of the 80 
study (d 0), and then daily for 30 days. Fecal samples were collected, placed in a Whirl-Pak® 81 
sample bag (Nasco, Fort Atkinson, WI) then placed in the refrigerator. Once all samples were 82 
collected (approximately one hour later), 3 g of feces was weighed and the remainder of sample 83 
was immediately frozen at -20°C for later analysis of opportunistic bacteria. Fecal parasite load 84 
was determined using the modified Wisconsin sugar flotation method and the centrifugation 85 
technique with a specific gravity between 1.20 to 1.33; strongyles, ascarids, and total eggs were 86 
counted and recorded [18,19]. 87 
2.2 Erythrocyte Sedimentation Rate 88 
Blood samples were collected via jugular venipuncture using a 5 mL syringe with a 20-89 
gauge, 1.5-inch needle and transferred to a 5 mL vacutainer K2 Ethylenediaminetetraacetic acid 90 
tube (Fischer Scientific, Franklin Lakes, NJ) for erythrocyte sedimentation rate (ESR) 91 
assessment (Globe Scientific, Paramus, NJ). The westergren ESR test was performed on days 0, 92 
3, 7, 10, 14, 17, 21, 24, and 28 to examine inflammation pre- and post-riding.  Samples collect on 93 
days 0, 7, 14, 21, and 28 were collected prior to riding. Samples collected on days 3, 10, 17, and 94 
24 were collected after four days of riding in which horses were ridden for an average of three 95 
hours per day.  96 
2.3 Fecal Analysis of Opportunistic Bacteria 97 
Growth of Bacteria 98 
 Pure cultures of selected opportunistic bacteria were grown and used as standards for 99 
qPCR. Trypticase soy broth (30 g/L) and yeast extract (3 g/L) medium was made for SBEC, 100 
according to Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) 101 
(Germany) media recipes. Clostridium medium (17 g/L digest casein, 3 g/L digest soy, 5 g/L 102 
NaCl, 2.5 g/L K2Pho4 and dextrose) was made for both C. difficile and C. perfringens, according 103 
to DifcoTM (Becton, Dickson and Company, Sparks, MD). Ten mL of broth was pipetted into 104 
glass Hungate tubes and deoxygenated with nitrogen. Rubber stoppers and metal caps were 105 
crimped on the tubes and then were autoclaved at 121°C, 15 psi, for 15 min. Hungate tubes were 106 
inoculated with pelleted strains of bacteria, C. difficile, C. perfringens, and SBEC. Dense 107 
bacterial samples were transferred to a new Hungate tube every three days for ten days to ensure 108 
pure cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) 109 
(Germany)). These pure cultures contained the forward and reverse primers in Table 1.  110 
DNA Extraction 111 
DNA was extracted from the daily fecal samples collected using PowerFecal Mo Bio 112 
DNA Extraction Kits (Mo Bio Laboratories, Carlsbad, CA). The pure cultures that were used as 113 
standards for qPCR (Bio-Rad MyiQ Optical System Software 2.0) were extracted using 114 
PowerFecal Mo Bio DNA Extraction Kits (Mo Bio Laboratories, Carlsbad, CA) and then 115 
purified using UltraClean 15 DNA Purification Kits (Mo Bio Laboratories, Carlsbad, CA). All 116 
DNA extractions were assessed for concentration using a Nano Drop ND-1000 117 
Spectrophotometer (Wilmington, DW). 118 
Real Time qPCR 119 
Real-time qPCR reactions were performed in triplicate using a MyIQ thermocycler 120 
(BioRad, Hercules, CA) in a total volume of 25 μL. The reaction mixture was composed of 121 
Maxima SYBR Green/ROX qPCR (Thermo Scientific, Waltham, MA), the corresponding 122 
forward and reverse primers (Eurofins MWG Operon, Louisville, KY) (Table 1), extracted DNA, 123 
and sterile water. The thermal cycling protocols for C. difficile [20], C. perfringens [21], and 124 
SBEC [22] were utilized at an average starting concentration of DNA at 52 ng/µL, 20 ng/µL, and 125 
17 ng/µL, respectively.  126 
2.4 Statistical Analysis 127 
All data were analyzed using the MIXED procedure of SAS (SAS 9.4 Inst., Inc., Cary, 128 
NC) for repeated measures. The model included treatment, day, and treatment × day interactions. 129 
An autoregressive covariance structure (AR1 of the MIXED procedure of SAS) was determined 130 
to be most appropriate based on Akaike’s Information Criterion. There were no treatment × day 131 
interactions; therefore, only treatment means are reported. Comparisons of main effects were 132 
determined using least square means and Fisher’s protected LSD (P ≤ 0.05) and a trend set at (P 133 
≤ 0.10). 134 
3. Results and Discussion 135 
3.1 Analysis of Intestinal Parasites 136 
Dosing curcumin at the recommended rate of 15 g per horse had no effect (P ≥ 0.58) on 137 
the amount of shedding of total fecal egg count, strongyles, or ascarids; however, there was a day 138 
effect. Total egg counts for both CON and CUR horses decreased (P ≤ 0.05) from d 1 to 10 then 139 
increased from d 11 to 19 followed by a decrease from d 20 to 29 with a substantial increase on d 140 
30. This pattern of decreasing and increasing ova was due to both strongyles (P = 0.05) and 141 
ascarids (P = 0.0007) decreasing and increasing for both CON and CUR horses. The increase 142 
and decrease of shed ova, approximately every ten days, would suggest the pattern of the 143 
strongyles lifecycle was observed [23]; these intestinal parasites can develop from an egg to 144 
larval stage 3 in a period of around one week in the optimal temperatures (8 – 38°C). The study 145 
was conducted at the onset of spring when it is expected for fecal egg counts to be higher than in 146 
the winter months [23, 24]. In contrast, when dosing cattle turmeric at 100 mg/ml a decrease in 147 
strongyles was observed [15]. The same dose was also determined to be 100% effective against 148 
adult gastrointestinal tract nematodes (roundworms) [15].  Similarly, a decrease in fecal egg 149 
shedding  was observed when goats were dosed 0.2% or 0.6% curcumin of the daily ration for 60 150 
days when compared to d 0 [16]. In the current study, it is possible that 30 days was not a long 151 
enough dosing period or that a larger dose is needed to observe the antiparasitic effects of 152 
curcumin. It should also be noted that treatments in the current study were randomly assigned 153 
prior to d 0 fecal egg counts and unfortunately most of the high shedding horses were randomly 154 
assigned to CUR, which could have influenced the results. The results would suggest that dosing 155 
curcumin for 30 days is not effective for intestinal parasite control in riding horses during the 156 
spring months of the Midwest region and that further research is needed to examine effects of 157 
curcumin with a longer dosing period or at an increased dose. In the current study, curcumin was 158 
utilized based on previous parasite work, mentioned above, and also do to its lower cost to 159 
supplement.  However, the bioavailability of curcumin is noted to be minimal due to being 160 
hydrophobic, low intrinsic activity, poor absorption, and high rate of metabolism and elimination 161 
from the body [25]. It is possible that the results would have been different had liposomal 162 
curcumin been utilized.  In rats, oral administration of liposome-encapsulated curcumin showed 163 
increased bioavailability of curcumin [26, 27].  164 
3.2 Erythrocyte Sedimentation Rate Analysis 165 
There were no treatment x time interactions and treatment had no effect on ESR (P ≤ 166 
0.42); however, a day effect (P ≤ 0.001) was observed (Table 2). ESR within the CUR horses, 167 
significantly decreased (P = 0.0006) on d 14 and again on d 21 (P = 0.02) compared to d 0 168 
(Figure 1). However, there was no difference (P = 0.64) between d 0 and d 28. There was no day 169 
effect (P = 0.29) for ESR in CON horses. This would suggest that it would take at least 14 days 170 
before curcumin could potentially decrease inflammation in riding horses. These findings are 171 
similar to Farinacci et al. (2009) [28], who observed curcumin down regulating COX-2, TNF- α, 172 
and IL-6 when mares and foals were administered 4mg/kg of CURCUVET®; and on d 15, COX-173 
2 was significantly down-regulated. However, in the current study inflammation on day 28 was 174 
not significantly different compared to day 0 which would further suggest that the bioavailability 175 
of curcumin is minimal, as previously discussed.  Moreover, factors such as an increase in 176 
ambient temperature, experience of the rider and saddle fit could have contributed to a similar 177 
ESR on day 28 compared to day 0.  178 
3.3 Fecal Analysis of Opportunistic Bacteria 179 
There was no treatment (P = 0.34) or day effect (P = 0.53) on concentration of C. 180 
perfringens (Table 2). Similarly, there was no treatment effect for C. difficile, (P = 0.51) or 181 
SBEC (P = 0.69). However, C. difficile, for both CON and CUR horses, had a significant day 182 
effect (P = 0.0001) with all horses having higher concentrations on d 0 and d 1 compared to all 183 
other days. Furthermore, concentrations of SBEC were affected by day (P = 0.05) with CON and 184 
CUR horses having similar concentrations at d 0 and d 1. However, the CON horses had an 185 
increase in SBEC concentration on d 9, 25, 27, and 30 when compared to d 0, while the CUR 186 
horses had increased concentrations on d 9, 17, and 27 compared to day 0. The data from this 187 
study would indicate that curcumin can be dosed at 15 g per day for 30 days with no adverse side 188 
effects on opportunistic bacteria concentrations, however, more research is needed to evaluate 189 
the antimicrobial properties of curcumin when dosed to horses over a longer duration and at 190 
varying dosages.  191 
5. Conclusions 192 
The antiparasitic and antimicrobial properties of curcumin were not observed when 15 g 193 
of curcumin was orally dosed to twelve riding horses for 30 days. The inability for curcumin to 194 
decrease the parasite shedding load would suggest that curcumin will need to be dosed for longer 195 
periods of time or at higher dosages, if utilizing for intestinal parasite control. However, it is 196 
possible that curcumin can decrease inflammation after 14 days of administration. More research 197 
is needed to further evaluate the benefits of supplementing curcumin to horses, especially for 198 
intestinal parasitic control. 199 
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  275 
Table 1. Forward and Reverse Primers used for real time PCR 276 
 277 
 
Strains 
   
       Reverse Primers (5’-3’) Forward Primers (5’-3’) 
SBEC1 
 
C. difficile2 
 
C. perfringens3 
GCCTACATGAAGTCGGAATCG            TACAAGGCCCGGGAACGTA 
 
CAAGTTGAGCGATTTACTTCGGTAA  CTAATCAGACGCGGGTCCAT    
   
AAATGTAACAGCAGGGGCA                 TGAAATTGCAGCAACTCTAGC 
1Streptococcus bovis/equinus complex [22] 278 
2Clostridium difficile [20] 279 
3Clostridium perfringens [21] 280 
  281 
Table 2. Effects of 15 g of 500 mg/g of 95% curcumin dosed once daily to riding horses on fecal 282 
parasite load (number of eggs/3 grams of feces), erythrocyte sedimentation rate, and fecal 283 
opportunistic bacteria. 284 
 285 
 286 
 Treatments1          P-Value 
Parameters CON CUR SEM TRT DAY 
Total Egg 127 156 37.8 0.58 0.05 
 
Strongyles 123 153 37.7 0.58 0.05 
 
Ascarids 3.22 3.11 0.24 0.74 0.0007 
 
ESR2, mm/hr 89.6 94.5 4.21 0.42 0.001 
      
SBEC3, ng/μL 1.93 1.66 0.46 0.69 0.04 
      
C. difficile, ng/μL  4108 8080 4136 0.51 0.0001 
 
C. perfringens, ng/μL 0.01 0.0001 0.01 0.34 0.53 
1 Treatments: CON= control; CUR= curcumin dosed at 15g/day 287 
2 Erythrocyte Sedimentation Rate 288 
3 Streptococcus bovis/equinus complex 289 
Figure 1. Effect of curcumin on Erythrocyte Sedimentation Rate over time (days). 290 
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